185 related articles for article (PubMed ID: 9311489)
1. Pulmonary surfactant in cystic fibrosis.
Griese M; Birrer P; Demirsoy A
Eur Respir J; 1997 Sep; 10(9):1983-8. PubMed ID: 9311489
[TBL] [Abstract][Full Text] [Related]
2. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
[TBL] [Abstract][Full Text] [Related]
3. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis.
von Bredow C; Birrer P; Griese M
Eur Respir J; 2001 Apr; 17(4):716-22. PubMed ID: 11401069
[TBL] [Abstract][Full Text] [Related]
4. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
[TBL] [Abstract][Full Text] [Related]
5. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
[TBL] [Abstract][Full Text] [Related]
6. Tracheobronchial surface active material in cystic fibrosis.
Griese M; Duroux A; Schams A; Lenz AG; Kleinsasser N
Eur J Med Res; 1997 Mar; 2(3):114-20. PubMed ID: 9113501
[TBL] [Abstract][Full Text] [Related]
7. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.
Griese M; Essl R; Schmidt R; Rietschel E; Ratjen F; Ballmann M; Paul K;
Am J Respir Crit Care Med; 2004 Nov; 170(9):1000-5. PubMed ID: 15271694
[TBL] [Abstract][Full Text] [Related]
9. Age-dependency of surfactant phospholipids and surfactant protein A in bronchoalveolar lavage fluid of children without bronchopulmonary disease.
Ratjen F; Rehn B; Costabel U; Bruch J
Eur Respir J; 1996 Feb; 9(2):328-33. PubMed ID: 8777972
[TBL] [Abstract][Full Text] [Related]
10. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
[TBL] [Abstract][Full Text] [Related]
11. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates.
Veldhuizen RA; Inchley K; Hearn SA; Lewis JF; Possmayer F
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):141-7. PubMed ID: 8216208
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary surfactant in birds: coping with surface tension in a tubular lung.
Bernhard W; Gebert A; Vieten G; Rau GA; Hohlfeld JM; Postle AD; Freihorst J
Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R327-37. PubMed ID: 11404309
[TBL] [Abstract][Full Text] [Related]
13. Surfactant composition in infants and young children with cystic fibrosis.
Hull J; South M; Phelan P; Grimwood K
Am J Respir Crit Care Med; 1997 Jul; 156(1):161-5. PubMed ID: 9230741
[TBL] [Abstract][Full Text] [Related]
14. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections.
Mander A; Langton-Hewer S; Bernhard W; Warner JO; Postle AD
Am J Respir Cell Mol Biol; 2002 Dec; 27(6):714-21. PubMed ID: 12444031
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary surfactant activity is impaired in lung transplant recipients.
Hohlfeld JM; Tiryaki E; Hamm H; Hoymann HG; Krug N; Haverich A; Fabel H
Am J Respir Crit Care Med; 1998 Sep; 158(3):706-12. PubMed ID: 9730994
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug.
Gunasekara L; Al-Saiedy M; Green F; Pratt R; Bjornson C; Yang A; Michael Schoel W; Mitchell I; Brindle M; Montgomery M; Keys E; Dennis J; Shrestha G; Amrein M
J Cyst Fibros; 2017 Sep; 16(5):565-572. PubMed ID: 28599957
[TBL] [Abstract][Full Text] [Related]
17. Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis.
Lesur O; Veldhuizen RA; Whitsett JA; Hull WM; Possmayer F; Cantin A; Bégin R
Lung; 1993; 171(2):63-74. PubMed ID: 8426464
[TBL] [Abstract][Full Text] [Related]
18. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation.
Veldhuizen RA; Lee J; Sandler D; Hull W; Whitsett JA; Lewis J; Possmayer F; Novick RJ
Am Rev Respir Dis; 1993 Jul; 148(1):208-15. PubMed ID: 8317801
[TBL] [Abstract][Full Text] [Related]
19. Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled alpha 1-protease inhibitor in cystic fibrosis.
Griese M; von Bredow C; Birrer P
Electrophoresis; 2001 Jan; 22(1):165-71. PubMed ID: 11197168
[TBL] [Abstract][Full Text] [Related]
20. Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis.
Seidl E; Kiermeier H; Liebisch G; Ballmann M; Hesse S; Paul-Buck K; Ratjen F; Rietschel E; Griese M
J Cyst Fibros; 2019 Nov; 18(6):790-795. PubMed ID: 31029606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
